Drug boosts survival in melanoma study

Wednesday, June 9, 2010 - 10:41 in Health & Medicine

Experimental ipilimumab is the first treatment to prolong the lives of those with the deadly skin cancer. The drug, which helps the immune system fight tumors, could be out by the end of the year. Researchers have scored the first big win against melanoma, the deadliest form of skin cancer. An experimental drug significantly improved survival in a major study of people with...

Read the whole article on LA Times - Health

More from LA Times - Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net